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(‘‘Preclose’’ technique)
W.A. Lee, M.P. Brown, P.R. Nelson and T.S. Huber
Objective. Percutaneous access during endovascular aneurysm repair has
been difficult owing to the large size of the delivery catheters. This study re-
ports a single-center experience of totally percutaneous access during endo-
vascular abdominal and thoracic aortic repairs using the Perclose Proglide
device (Abbott Vascular, Redwood City, Calif).
Methods. Between December 2004 and August 2006, 262 endovascular aortic
aneurysm repairs were performed. Percutaneous access was used for the in-
troduction of 12F to 24F sheaths (4.4-mm to 8.6-mm outer diameter). The
technique involved deployment of two Proglide devices before insertion of
the sheath (‘‘Preclose’’ technique) with the sutures left extracorporeally for
closure after conclusion of the procedure. A prospectively maintained endo-
vascular database and medical records were retrospectively reviewed. Rates
of technical success, failure modes, and the overall duration of the endovas-
cular repair compared with a similar cohort using open femoral exposures
were examined.
Results. A total of 559 Proglide devices were used to close 279 femoral ar-
teries, and 175 (63%) required the insertion of 18F to 24F sheaths. There
were 16 failures, mainly due to obesity, device malfunction, severe calcific
disease, and faulty arterial punctures, for a technical success rate of 94.3%.
The success rates for 12F to 16F size sheaths were significantly higher than
for the larger 18F to 24F sheaths (99.0% vs 91.4%, P< .01). For both endovas-
cular abdominal (EVAR) and thoracic (TEVAR) aortic repairs, the Preclose
technique resulted in shorter overall procedure times compared with a similar
cohort in which open femoral exposures were used (EVAR, 115 vs 128 min,
P< .001; TEVAR, 80 vs 112, P¼ .019). Despite this reduction of procedure
time, the savings on the cost of operating room time was negated by the
cost of the Proglide devices ($295 per device).
Conclusions. Percutaneous access for endovascular aortic repair is safe and
feasible using the Proglide device. Although the success rates are higher
for smaller size sheaths, successful closures may be obtained for up to 24F
sheaths. Percutaneous access may result in shorter overall procedure times
and potentially lower operating room costs, but this appears to be offset by
the cost of the closure devices.
Objective scoring systems of medical risk: A clinical tool for selecting
patients for open or endovascular abdominal aortic aneurysm repair
R. Faizer, G. DeRose, D.K. Lawlor, K.A. Harris and T.L. Forbes
Background. Objective scoring systems have been developed for risk stratifi-
cation of open infrarenal aneurysm repair. To date, none have been applied
for the selection of patients who would most benefit from either an open or
an endovascular approach. This study assessed the utility of comorbidity-
based objective scoring systems for defining subgroups of patients who
might most benefit from open or endovascular aneurysm repair.
Methods. A retrospective database review was performed for the period Jan-
uary 1999 to December 2004 to identify patients who had undergone elective
open aneurysm repair (open repair) or elective endovascular aneurysm repair
(EVAR). Validation of the Glasgow Aneurysm Score (GAS), the Modified
Leiden Score (M-LS), and the Modified Comorbidity Severity Score
(M-CSS) was performed for perioperative mortality risk in the open repair
group. GAS, M-LS, and M-CSS were then calculated for the EVAR group. Dif-
ferences in open repair vs EVAR mortalities were evaluated.
Results. During the time period, 558 patients underwent open repair and 304
underwent EVAR. Overall mortality was 4.7% for open repair patients and
2.0% for EVAR. All three scoring systems were validated to our open repair
data set (C statistic: GAS, 0.72; M-LS, 0.71; M-CSS, 0.74). A score was
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1078e5884/000757+ 03 $32.00/0  2007 Published by Elsevier Ltd.calculated for each system that separated patients into groups of either low
or high risk of death for open repair. This score (cut point) was 76.5 for the
GAS, 5.2 for the M-LS, and 8 for the M-CSS. Analysis of the EVAR population
revealed that patients at low medical risk for open repair did not derive sta-
tistically significant mortality benefit with EVAR; however, patients at high
medical risk for open repair derived significant benefit from EVAR (GAS
>76.5 mortality: open repair, 7.8%; EVAR, 1.9% [P< .01]; M-LS mortality:
open repair, 8.1%; EVAR, 2.5% [P< .01]; and M-CSS mortality: open repair,
10.3%; EVAR, 3.4% [P< .025]). Despite a very small number of deaths
(n¼ 6), receiver operator curve analysis identified M-LS and M-CSS as hav-
ing some predictive ability for mortality risk with EVAR (C statistic: M-LS,
0.70; M-CSS, 0.69).
Conclusion. Three validated objective scoring systems can be used to catego-
rize patients into two groups of medical risk: one that has excellent outcome
with open repair and derives no early mortality benefit from EVAR, and an-
other that has significant mortality with open repair and derives important
benefit with EVAR.
Effectiveness of intensive medical therapy in type B aortic dissection:
A single-center experience
G. Tefera, C.W. Acher, J.R. Hoch, M. Mell and W.D. Turnipseed
Objective. Although the mainstay of managing acute descending thoracic
aortic dissection (ADTAD) remains medical, certain patients will require
emergency surgery for complications of rupture or ischemia. This study eval-
uates factors that affect outcome and determines which patients previously
treated surgically would have been eligible for endovascular repair.
Methods. A single-institution retrospective study was conducted of patients
who presented with clinical signs of ADTAD that was confirmed by magnetic
resonance angiography (MRA) or computed tomography (CT). All patients
were admitted to the intensive care unit (ICU) and medically managed to
maintain systolic blood pressure <120 mm Hg and heart rate <70 beats/
min. Two treatment groups were identified: group 1 received medical treat-
ment only; group 2 received medical treatment plus emergency surgery.
Patient demographic and clinical data were correlated with 30-day group
mortality and morbidity and need for emergency surgery. The MRA and
CT scan images of group 2 were retrospectively reviewed to determine if cur-
rently available endovascular treatment could have been done. The Fisher ex-
act test was used to compare between the groups, and P< .05 was considered
significant.
Results. Between 1991 and 2005, 83 patients (55 men) were treated for AD-
TAD. The mean age was 67 years (range, 38 to 85). Sixty-eight patients
(82%) had hypertension, three (3.6%) had Marfan syndrome, and 51 (62%)
were smokers. Twenty-five (32%) of the patients were receiving b-blocker
therapy before the onset of their symptoms. Back pain was the most common
initial symptom (72.2%). Emergency surgery was required in 19 patients
(23%): 12 for rupture or impending rupture, four for mesenteric ischemia,
and three for lower extremity ischemia. The need for emergency surgery
was significantly higher in smokers (P¼ .03), in patients >70 years old
(P¼ .035), and in patients who were not receiving b-blocker therapy before
the onset of symptoms (P¼ .023). The combined overall morbidity rate was
33%, and the mortality rate was 9.6%. Morbidity in group 2 was 64% and sig-
nificantly higher than the 23% in group 1 (P¼ .00227). The mortality rate was
also higher in group 2 at 31.5% compared with group 1 at 1.6% (P¼ .0004).
Factors affecting the overall mortality included age >70 years (P¼ .057), pre-
vious abdominal aortic aneurysm repair (P¼ .018), tobacco use (P¼ .039), and
the presence of leg pain at initial presentation (P¼ .013). As determined from
the review of radiologic data, 11 of 13 patients with scans available for review
in group 2 could have been treated with currently available endovascular
grafts.
Conclusions. Intensive medical therapies are effective in preventing early
mortality associated with ADTAD. Predictably, the need for emergency sur-
gery carries a high morbidity and mortality rate. Most patients in this series
requiring emergency surgery could have been candidates for endovascular
therapy had it been available.3 May 2007  757/759
758 AbstractsTreatment of type II endoleak with a transcatheter transcaval approach:
Results at 1-year follow-up
G. Mansueto, D. Cenzi, A. Scuro, L. Gottin, A. Griso, A.A. Gumbs and
R.P. Mucelli
Purpose. This study assessed the feasibility and mid-term outcomes in the
treatment of type II endoleak using transcatheter transcaval embolization
(TTE).
Methods. During an 8-month period, 12 patients underwent TTE. After direct
transcaval puncture of the aneurysm sac, embolization was performed by in-
jecting thrombin and placing coils. Systemic and intrasac pressures were re-
corded throughout the entire procedure. Computed tomography (CT) scans
were performed at 24 hours, 30 days, 6 months, and 1 year after TTE to eval-
uate endoleaks and changes in sac diameter. Technical success was defined as
the feasibility of the procedure; clinical success was defined as no evidence of
leaks during the follow-up evaluation.
Results. TTE was feasible in 11 of 12 patients (technical success 92%). The
mean systemic pressure was 117 mm Hg. The mean intrasac pressure before
embolization was 75 mm Hg (range, 39 to 125 mm Hg), 16.5 mm Hg (range, 7
to 40 mm Hg) in 10 patients after embolization, and it increased in one pa-
tient. CT scans at 24 hours showed stable contrast medium inside the sac
in 10 patients. Only minor complications were observed during follow-up.
At the 1-year follow-up, no recurrence of leaks was noted, and sac diameter
was reduced in 10 of 11 patients. As a result, TTE clinical success was
obtained in 10 (83%) of 12 patients.
Conclusion. TTE appears to be a feasible technique for the complete exclusion
of type II endoleaks. Technical and clinical successes are comparable with
other treatment strategies and TTE should be considered an alternative to
direct translumbar puncture of the aneurysm sac.
Relationship between temporal-spatial gait parameters, gait kinematics,
walking performance, exercise capacity, and physical activity level in
peripheral arterial disease
R.G. Crowther, W.L. Spinks, A.S. Leicht, F. Quigley and J. Golledge
Objective. Impaired physical function is a feature of patients with peripheral
arterial disease (PAD) who present with symptoms of intermittent claudica-
tion (PAD-IC). Previous research found that temporal-spatial gait parameters
do not discriminate between PAD-IC patients and control subjects during
normal and maximal walking even though PAD-IC patients have decreased
physical function characteristic of the disease. This study examined the
hypothesis that patients with PAD-IC would demonstrate decreased
temporal-spatial gait parameters, gait kinematics, walking performance,
physiologic responses to exercise, and physical activity level compared
with control subjects. The aim was to examine the temporal-spatial gait pa-
rameters and gait kinematics of individuals with PAD-IC and to determine
the relationship between these variables and walking performance, exercise
capacity, and physical activity level in these individuals.
Method. A cross-sectional study of 28 PAD-IC subjects (IC) and 25 controls
(CON) matched for age and mass was conducted in a medical faculty human
performance laboratory. IC subjects had a history of PAD, ankle-brachial
pressure index (ABI) <0.9 in at least one leg, and a positive Edinburgh Clau-
dication Questionnaire response. Gait characteristics were determined by
two-dimensional motion analysis. A graded treadmill test was used to assess
walking performance and peak physiologic responses to exercise. Physical
activity levels were measured by analysis of 7-day pedometer recording
motion. Differences between groups were examined by one-way analysis
of covariance.
Results. Compared with CON, IC temporal-spatial gait parameters were
significantly lower (P< .05), except for single support ipsilateral limb
time. IC subjects spent a greater percentage of time in gait support phases,
took longer to complete a stride, and had reduced stride length and walk-
ing speeds during the gait cycle. IC joint angular kinematics showed signif-
icantly reduced displacement of ankle plantar flexion (P ¼ .017), knee range
of motion (P ¼ .021), and hip extension (P ¼ .016) compared with the CON
subjects during the gait cycle. All joint minimum and maximum angular
velocities and accelerations, walking physiologic responses, and physical
activity levels were significantly lower for IC compared with the CON
subjects.Eur J Vasc Endovasc Surg Vol 33, June 2007Conclusion. IC subjects walk with a shuffling gait pattern indicated by re-
duced joint angular displacement, velocities, and accelerations that results
in reduced walking performance and physiologic and physical activity com-
pared with controls matched for age, mass, and physical activity.
The treatment of disabling intermittent claudication in patients with
superficial femoral artery occlusive diseasedDecision analysis
B. Nolan, S. Finlayson, A. Tosteson, R. Powell and J. Cronenwett
Objective. To determine the preferred approach to superficial femoral artery
(SFA) revascularization of Trans-Atlantic Inter-Societal Consensus (TASC) B
and C lesions in claudicants requiring intervention based on a review of
published data.
Design. Decision analysis, Markov state transition model.
Subjects. Hypothetical cohorts of claudicants with TASC B or TASC C super-
ficial femoral artery lesions considered candidates for either angioplasty with
selective stenting (PTA/S) or greater saphenous vein bypass (GSVB).
Main outcome measure. Quality adjusted life years (QALYs).
Results. For a 65-year-old man with disabling claudication, percutaneous
transluminal angioplasty and selective stenting (PTA/S) was preferred over
GSVB for a TASC B SFA lesion. In an otherwise identical patient with
a TASC C lesion, bypass was the preferred therapy. Treating PTA/S failures
with subsequent bypass increased the utility of PTA/S but bypass remained
the preferred initial therapy for TASC C lesions. Sensitivity analysis showed
that PTA/S surpasses bypass efficacy for TASC C lesions if PTA/S primary
patency is >32% at 5 years, patient age is >80 years, or GSVB operative
mortality is >6%.
Conclusion. PTA/S is the preferred initial therapy over GSVB for TASC B SFA
lesions in patients with disabling intermittent claudication who require inter-
vention. Given contemporary published outcomes for TASC C lesions, GSVB
is the preferred therapy in operative candidates. In elderly patients or pa-
tients at high risk for bypass, PTA/S should be considered over GSVB. Im-
proved technology that results in a 5-year primary patency of 32% would
also justify PTA/S for TASC C SFA lesions.
The complete management of extremity vascular injury in a local
population: A wartime report from the 332nd Expeditionary Medical
Group/Air Force Theater Hospital, Balad Air Base, Iraq
M.A. Peck, W.D. Clouse, M.W. Cox, A.N. Bowser, J.L. Eliason, D.H. Jenkins,
D.L. Smith and T.E. Rasmussen
Background. Although the management of vascular injury in coalition forces
during Operation Iraqi Freedom has been described, there are no reports on
the in-theater treatment of wartime vascular injury in the local population.
This study reports the complete management of extremity vascular injury
in a local wartime population and illustrates the unique aspects of this cohort
and management strategy.
Methods. From September 1, 2004, to August 31, 2006, all vascular injuries
treated at the Air Force Theater Hospital (AFTH) in Balad, Iraq, were regis-
tered. Those in noncoalition troops were identified and retrospectively
reviewed.
Results. During the study period, 192 major vascular injuries were treated in
the local population in the following distribution: extremity 70% (n¼ 134),
neck and great vessel 17% (n¼ 33), and thoracoabdominal 13% (n¼ 25).
For the extremity cohort, the age range was 4 to 68 years and included 12 pe-
diatric injuries. Autologous vein was the conduit of choice for these vascular
reconstructions. A strict wound management strategy providing repeat oper-
ative washout and application of the closed negative pressure adjunct was
used. Delayed primary closure or secondary coverage with a split-thickness
skin graft was required in 57% of extremity wounds. All patients in this co-
hort remained at the theater hospital through definitive wound healing, with
an average length of stay of 15 days (median 11 days). Patients required an
average of 3.3 operations (median 3) from the initial injury to definitive
wound closure. Major complications in extremity vascular patients, including
mortality, were present in 15.7% (n¼ 21). Surgical wound infection occurred
in 3.7% (n¼ 5), and acute anastomotic disruption in 3% (n¼ 4). Graft throm-
bosis occurred in 4.5% (n¼ 6), and early amputation and mortality rates dur-
ing the study period were 3.0% (n¼ 4) and 1.5% (n¼ 2), respectively.
759AbstractsConclusions. To our knowledge, this study represents the first large report of
wartime extremity vascular injury management in a local population. These
injuries present unique challenges related to complex wounds that require
their complete management to occur in-theater. Vascular reconstruction using
vein, combined with a strict woundmanagement strategy, results in successful
limb salvage with remarkably low infection, amputation and mortality rates.
Compression after sclerotherapy for telangiectasias and reticular leg
veins: A randomized controlled study
P. Kern, A.-A. Ramelet, R. Wu¨tschert and D. Hayoz
Background. The efficacy of wearing compression stockings on clinical vessel
disappearance following sclerotherapy of telangiectasias and reticular veins
has been a matter of debate for half a century.
Objective. To determine the relative efficacy of compression following sclero-
therapy and to determine its impact on general quality of life in a prospective
randomized open-label trial.
Methods. Female patients seeking treatment of telangiectasias and reticular
veins and presenting comparable areas of telangiectasias on the lateral aspect
of the thigh (C1A or SEPAS1PN) were randomized to wear medical compressionstockings (23 to 32 mm Hg) daily for 3 weeks or no such treatment following
a single session of standardized liquid sclerotherapy. Outcome was assessed
by patient satisfaction analysis and quantitative evaluation of photographs
taken from the lateral aspect of the thigh before and again at 52 days on
the average after sclerotherapy by two blinded expert reviewers. Patients
completed a quality of life questionnaire (SF-36) before treatment and again
at the control.
Results. Data of 96 of 100 randomized patients could be evaluated. Patient
satisfaction with the outcome of treatment was similar in the two groups. Ob-
jective assessment of clinical vessel disappearance revealed a benefit of wear-
ing stockings (P¼ .026) corresponding to a NNT (number needed to treat) of
4.7 patients to get a vessel disappearance score higher than 6. The inter-
observer agreement was very high (intraclass correlation coefficient¼ 0.93).
Compression was well tolerated with a low rate of discomfort claims
(mean 17.5%). Micro-thrombi were rarely observed in either group, but still
less prevalent in the compression group. The rate of pigmentation and
matting was low and did not differ significantly between the two groups.
Physical and mental quality of life scores in women seeking treatment of tel-
angiectasias were similar to those of a healthy control population. Treatment
had no impact on general quality of life.
Conclusion. Wearing compression stockings (23 to 32 mm Hg) for 3 weeks en-
hance the efficacy of sclerotherapy of leg telangiectasias by improving clinical
vessel disappearance.Eur J Vasc Endovasc Surg Vol 33, June 2007
